Skip to main content

Agena Bioscience VeriDose CYP2D6 CNV Panel

Agena Bioscience has launched the VeriDose CYP2D6 CNV panel to provide PGx testing programs with a more accurate and efficient way to analyze CYP2D6 copy number. The research-use-only panel quantifies CYP2D6 copy number even in the presence of CYP2D6/CYP2D7 hybrid alleles, which cannot be detected by commonly used PGx technologies, the company said. The panel can also be run alongside Agena's PGX genotyping panels.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.